We are upgrading the repository! A content freeze is in effect until November 22nd, 2024 - no new submissions will be accepted; however, all content already published will remain publicly available. Please reach out to repository@u.library.arizona.edu with your questions, or if you are a UA affiliate who needs to make content available soon. Note that any new user accounts created after September 22, 2024 will need to be recreated by the user in November after our migration is completed.
Successful resolution of hyperammonemia following hematopoietic cell transplantation with directed treatment of Ureaplasma parvum infection
Name:
Katsanis_Hyperammonemia_with_f ...
Size:
111.5Kb
Format:
PDF
Description:
Final Accepted Manuscript
Affiliation
Univ Arizona, Dept PediatUniv Arizona, Ctr Canc
Issue Date
2018-04
Metadata
Show full item recordPublisher
WILEYCitation
Graetz R, Meyer R, Shehab K, Katsanis E. Successful resolution of hyperammonemia following hematopoietic cell transplantation with directed treatment of Ureaplasma parvum infection. Transpl Infect Dis. 2018;20:e12839. https://doi.org/10.1111/tid.12839Journal
TRANSPLANT INFECTIOUS DISEASERights
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Hyperammonemia following hematopoietic cell transplantation (HCT) has been characterized as idiopathic and is associated with a very high mortality. A causal relationship between Ureaplasma infection and hyperammonemia in immunocompromised lung transplant recipients has recently been described. We document the first case of hyperammonemia following HCT associated with Ureaplasma parvum. The initiation of appropriate antibiotics resulted in rapid resolution of hyperammonemic encephalopathy and eradication of the implicating organism.Note
12 month embargo; published online: 23 January 2018ISSN
1398-22731399-3062
PubMed ID
29359847Version
Final accepted manuscriptAdditional Links
https://onlinelibrary.wiley.com/doi/abs/10.1111/tid.12839ae974a485f413a2113503eed53cd6c53
10.1111/tid.12839
Scopus Count
Collections
Related articles
- Hyperammonemic Encephalopathy due to Ureaplasma parvum Infection in an Immunocompromised Child.
- Authors: Smith M, Crews JD, Cheek N, Srivastava R, Appachi E
- Issue date: 2019 Aug
- Successful treatment of Ureaplasma-induced hyperammonemia syndrome post-lung transplant.
- Authors: Matson KM, Sonetti DA
- Issue date: 2019 Feb
- Hyperammonemia From Ureaplasma Infection in an Immunocompromised Child.
- Authors: Placone N, Kao RL, Kempert P, Ruiz ME, Casillas JN, Okada M, Gibson JB, Maggi C, O'Brien K, Nattiv R, Gallant NM, Abrams SH
- Issue date: 2020 Mar
- Disseminated Ureaplasma infection as a cause of fatal hyperammonemia in humans.
- Authors: Bharat A, Cunningham SA, Scott Budinger GR, Kreisel D, DeWet CJ, Gelman AE, Waites K, Crabb D, Xiao L, Bhorade S, Ambalavanan N, Dilling DF, Lowery EM, Astor T, Hachem R, Krupnick AS, DeCamp MM, Ison MG, Patel R
- Issue date: 2015 Apr 22
- Hyperammonemia syndrome due to Ureaplasma infection after liver-kidney transplant.
- Authors: Cannon CA, Corcorran MA, Shaw KW, Montenovo M, Sibulesky L, Reyes JD, Rayhill SC, Larson AM, Kritek PA, Giovanni S, de Castro I, Arora N, Rakita RM
- Issue date: 2020 Jun